almotriptan has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csiba, L; Ficzere, A | 1 |
| Docekal, P; Falk, RM; Ferrer, P; Luria, X; Pascual, J; Piessens, F; Prusinski, A; Robert, M; Segarra, R; Zayas, JM | 1 |
1 review(s) available for almotriptan and Myocardial Ischemia
| Article | Year |
|---|---|
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2002 |
1 trial(s) available for almotriptan and Myocardial Ischemia
| Article | Year |
|---|---|
Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Molecular Structure; Myocardial Ischemia; Reproducibility of Results; Safety; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines | 2000 |